Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365)

UCI-16-76
NCT02861573
Cancer - Prostate
Nataliya Mar
Open
Treatment
Docetaxel, Enzalutamide, Olaparib, Pembrolizumab, Prednisone, Taxotere
Ib/II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.